The National Institute of Mental Health awarded a purchase order to Oxford Stemtech LTD for $244,497 on September 24, 2026, for diagnostic laboratory services supporting the generation and characterization of organoids. Work is performed in Great Britain, United Kingdom. The order covers induced pluripotent stem cell quality control and differentiation services under a firm fixed-price commercial item procurement conducted via FAR 12.603 authority. Ultimate completion is due May 23, 2027.